Przejdź do zawartości
Merck

Przejdź do

SCP0169

HIV-1 Tat Peptide

≥95% (HPLC), lyophilized powder

HIV-TAT (48-57)
1 of 1 reviewers received a sample product or took part in a promotion
Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok
Do Państwa/SKUDostępnośćCena netto
1 mg
Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności
846,00 zł

Informacje o tej pozycji

Wzór empiryczny (zapis Hilla):
C65H124N34O13
Masa cząsteczkowa:
1589.90
UNSPSC Code:
12352202
NACRES:
NA.32

846,00 zł


Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności

Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc


Nazwa produktu

HIV-TAT (48-57),

assay

≥95% (HPLC)

form

lyophilized

composition

Peptide Content, ≥55%

storage condition

protect from light

storage temp.

−20°C

General description

Human immunodeficiency virus (HIV)-transactivator of transcription (Tat), a regulatory protein is coded by the Tat gene of HIV-1. Tat is made up of two exons, highly conserved regions, and subtype-specific regions.[1]

Biochem/physiol Actions

Human immunodeficiency virus (HIV)-transactivator of transcription (Tat) participates in the pathogenesis of HIV-related complications. Tat protein is also involved in HIV-related cardiac dysfunction.[1] HIV-TAT (48-57) is used to facilitate the internalization of synthetic peptides.
Ta strona może zawierać tekst przetłumaczony maszynowo.

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 1

Ta pozycja
H0292SRP0452SAB5700590
description

-

description

-

description

recombinant, expressed in E. coli, ≥90% (SDS-PAGE)

description

-

assay

≥95% (HPLC)

assay

-

assay

≥90% (SDS-PAGE)

assay

>95% (HPLC), >95% (SDS-PAGE)

form

lyophilized

form

lyophilized powder

form

aqueous solution

form

lyophilized powder

storage condition

protect from light

storage condition

-

storage condition

-

storage condition

-

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−70°C

storage temp.

−20°C

composition

Peptide Content, ≥55%

composition

-

composition

-

composition

-


Klasa składowania

11 - Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable



Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumenty section.

Proszę o kontakt, jeśli potrzebna jest pomoc Obsługa Klienta

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów



Questions

Reviews

Active Filters

    • Review 1
    • Votes 3
    1 out of 5 stars.

    Purchase a different product

    Quite disappointed in this product. For one, they do not provide any information on reconstitution of this lyophilized powder, not even whether to use dH20 or not. Additionally, please look closely at the 3 cited papers that allegedly used this product. One is a review that didn't actually use the product, and the other two are from the same lab that published what looks to be the same experiment twice, but without sufficient methodology. They list that, "Fusion proteins containing ITIMs and HIV-TAT48–57 and its negative control containing only HIV-TAT48–57 were custom-designed and synthesized by Peptron Inc. (Daejeon, Korea)" which is not this product? Additionally, their only methodology in terms of use does not include reconstitution, merely this sentence hidden below a figure, "Cells were pre-treated with 5 µM of TAT, TAT–YADL, TAT–YVTM, TAT–YASL, TAT–YCNM or TAT–YSTI for 30 min before stimulation with 1 µg/ml of lipopolysaccharide (LPS) for 24 h."

    When I contacted a rep about my concerns they said they couldn't help with reconstitution instructions and I should have checked to see if they had instructions before purchasing.... a less than stellar response. Save yourself the time, money, and hassle and find a different product.

    Helpful?

    1. Response from Merck KGaA:

      Thank you for taking the time to leave a review. We are sorry to hear that your experience did not meet expectations. Our Technical Service team has reached out to you with additional resources in effort to resolve this issue. We apologize for any inconvenience this may have caused.